{"name":"Align Technology","slug":"align-tech","ticker":"ALGN","exchange":"NASDAQ","domain":"aligntech.com","description":"Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.","hq":"Tempe, Arizona, USA","founded":0,"employees":"20275","ceo":"Joe Hogan","sector":"Dental / MedTech","stockPrice":161.72,"stockChange":-0.03,"stockChangePercent":-0.02,"marketCap":"$11.6B","metrics":{"revenue":4095789056,"revenueGrowth":6.2,"grossMargin":70.1,"rdSpend":369911000,"netIncome":410351000,"cash":1059833984,"dividendYield":0,"peRatio":27.2,"fiscalYear":"FY2010"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Align Technology Reports Fourth Quarter and Full Year 2023 Results","summary":"Align Technology reported fourth quarter and full year 2023 results, with revenue of $1.43 billion and $5.45 billion, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-11-16","type":"deal","headline":"Align Technology Announces Strategic Partnership with SmileDirectClub","summary":"Align Technology announced a strategic partnership with SmileDirectClub to expand its clear aligner business.","drugName":"","sentiment":"positive"},{"date":"2023-08-18","type":"regulatory","headline":"Align Technology Receives FDA Clearance for iTero Element 5D Plus Scanner","summary":"Align Technology received FDA clearance for its iTero Element 5D Plus scanner, a digital intraoral scanner for dental applications.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5aZGk4QjhRcE5HdkVVTktLWmstNHl6UTVLTzlGSDQtTlN1SWtZX0ZMM3pCOVN0UnR4V1gtNWFFZDBINXRieEpkNW9tWjA2dmpNMXhsUDE2SXFQbnpLX1VMOFVnZ9IBY0FVX3lxTE5aZGk4QjhRcE5HdkVVTktLWmstNHl6UTVLTzlGSDQtTlN1SWtZX0ZMM3pCOVN0UnR4V1gtNWFFZDBINXRieEpkNW9tWjA2dmpNMXhsUDE2SXFQbnpLX1VMOFVnZw?oc=5","date":"2026-04-06","type":"pipeline","source":"Bitget","summary":"ALGN vs. WST: Which Stock Is the Better Value Investment Right Now? - Bitget","headline":"ALGN vs. WST: Which Stock Is the Better Value Investment Right Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQSXJNSkVsTDdZb3NfSlMwblZJLXB3RzByY2ZLZGE3bl9xTTJWTVVtb2lHSlBYelYxeTc5UUt2bnZzSW1wcWp0cUl1eklCcWRRUXc5WF8yeG4xQ0pNU0hiNWhiNGxxbnRFcl9jYzRNczU3TUU2SUgtdFVkaE5CeXY5QUxsdlVzZDZQSk4zcGtKVmU4Zw?oc=5","date":"2026-04-06","type":"deal","source":"Yahoo Finance","summary":"ALGN vs. WST: Which Stock Should Value Investors Buy Now? - Yahoo Finance","headline":"ALGN vs. WST: Which Stock Should Value Investors Buy Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPVjl5MjdOajRNVGlQQnhHYk9IR2d1ZGJnV1ZiSk1VczZyQjJESHlfYWhPcC1Ya0NvZE9hQk8xODNnWGxTYVgtTjc3Y0RNNWVMM2xMRUl2bkFlSGt0VXNOWXNqSFNpMVR0bnNRby1UUVpjczVhWVBGQjRtdkJZem94eDF0VmN2SFZlQjNvalRyTkF4MFB4eVhSZzEzalE?oc=5","date":"2026-03-19","type":"pipeline","source":"Yahoo Finance","summary":"ALGN or WST: Which Is the Better Value Stock Right Now? - Yahoo Finance","headline":"ALGN or WST: Which Is the Better Value Stock Right Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNbEhNa3JNVC1kaE5MTklJT3BMd2pQSGlLVGNkTFhNamFyRkRsUUVDSVVzN1BFelM0UVpZZkZyTGxzTlVxV09MeGZPM01SV2NUeVJROUl1Y1FkQUlwQVFnQ3BNRVNzVzRKRHJBUHR3aFBnMnhsUWctdEppMlJoYm9iUmR0aWZpeXZldktlUGhUV3dTd1M0aHhWZGhOWk41eW9PaENSR25NMloxY3ctMW04VGNlZE4zR0NZZFhfZXNIc3dVQQ?oc=5","date":"2026-03-06","type":"pipeline","source":"TradingView","summary":"Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio? - TradingView","headline":"Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio?","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOQW56dlhVY0xQZWwxZGtXSFpyRWlHbXN0Z2UxR0ZNendabGFKZFhVbFc2b3NOU0tGSUZEbXZtRGhJVVcxaWdaalNIVFVSQjd3M1JrUkd0NE54YnFiYWdFZzNiNGVIRmpWYmtjUGszMEd6Vkk2bVh0ZmoxZjgwM1NNRVhtYzBkc05aZDR3?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance","headline":"Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQbjYxTndOSWhLcEJmd1N3NzVSNDU0MENkZWlwVTRBd3hTb19OZEpiNHEwSk1fZGtrZnlBSlVJZGg1d244YmJTOVdSOTVTZktwVXk1N3F1RGhiOHFDZHc4NS1TMXM1alpJa2dLb2gyZm1QWHktSjM1M2JXckdnT0prakkzZWVlZHh5M2tuTzVJcy1TUGZaUk9fWTdhUTh5cUpNZktDdThBS0R5aXc4cmhJaXNIMGkxRGNyWWJ0ZTMydw?oc=5","date":"2026-02-04","type":"pipeline","source":"Stock Titan","summary":"Maker of Invisalign has 22M patients and $4B in annual sales - Stock Titan","headline":"Maker of Invisalign has 22M patients and $4B in annual sales","sentiment":"neutral"},{"date":"2026-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-05","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOUHFxaXNZRy14cE5pOW1nbVh3aEVjV0VVX0h6dzRRR0NnMzRYQy1BMnNmcUp3TnM3ZzZUZGNkbXlVNHZEam9pVGUzT0lZNlhUZDFXQUt5TzZWbTJhc1Axd3kzRklZMDNaa1VoOVZPTWNsOU5pS0pNLXlOZEhwZVBOQVdzN3dvWU1IeUZFYWFHX0dkbVZxZTlxVFBzQ2FKZw?oc=5","date":"2025-11-01","type":"pipeline","source":"The Motley Fool","summary":"Navera Dumps $123 Million Worth of Align Technology (ALGN) Stock - The Motley Fool","headline":"Navera Dumps $123 Million Worth of Align Technology (ALGN) Stock","sentiment":"neutral"},{"date":"2025-10-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNTkw1dF85dmtQZHVBN0p6SzBDazJrMWVoaVJabmNja3F6TU4yRVVGLU9tc2Zza2c2TENGbmVmbHpMbURWd1JoN2toNW9DMWptcVU0dWY0QzBSbG84anROeVZFZUtkYUxSTmQ2cW0xNUFxNXJnRzBoLWprYVZOc2duWXhvNVQ3ck1tMF9EdjRjZnZrMGV1WkFlQm8yZkdZd2tSXzZEaG9USXRRdU50dEVreEhtT0lLY2xkZ0Utbm1ZUzd2UHJSUTVvUWl4V1VQSmg4MnBRQm9WbVMyUQ?oc=5","date":"2025-10-16","type":"pipeline","source":"The Globe and Mail","summary":"1 Healthcare Stock Worth Investigating and 2 We Question - The Globe and Mail","headline":"1 Healthcare Stock Worth Investigating and 2 We Question","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOUThsdUdJZFlUSUxNLUlGS0RYU2JOQ1BwV0xsejh5MmNYam51ejdxV3RUZEJKczg5dTNsbWF1dFVRVXNKcll6TU43SEFXRzdkZWxJUF9wTV9MN01vanhXM0FXRUxhdmlkSm8tbUFZSDdjZ3FyTkNXeUl3RjJ5N3VyVldka0JFRnlabjZRa3RQOTU2a2VSbncxcnpqZjRzRzFNTzgwMXJTMmlhYXVMcExqRW03MVhSN05qVVE2M3Z1TUdOVFp3bDBlM2poYTAzODVCQ0xXUS0yWmN2ZWxSelNjVWhEbUl1eEh5c3Vxal9OVXhhT2ZXd0NkNVBsS1hxb3Q4X2RwcA?oc=5","date":"2025-10-10","type":"pipeline","source":"StockStory","summary":"Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know - StockStory","headline":"Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPeENCeHFRa1pIRXFjUW5iTklUYk5BaXlZU1B6V3JYdUlRS2FSOVZGN1dLUVF0SEVxRXNNUkVEa0VyVHVCcFA3dERjMjRlSTBTYkVvdmtiNmZMenRtN2hIS0x0OXdyczBXVDB0cjdrS0dBel8zVkdvWEQyR3dEVzdoM3R3Y0dJS2UxWEF0WnAzbXFXTm8?oc=5","date":"2025-09-30","type":"pipeline","source":"Seeking Alpha","summary":"Align Technology: Moat Is Deteriorating Gradually - Seeking Alpha","headline":"Align Technology: Moat Is Deteriorating Gradually","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Dentsply Sirona","Henry Schein","Stryker"],"therapeuticFocus":["Orthodontics","Dental"],"financials":{"source":"sec_edgar+yahoo","revenue":387126000,"revenuePeriod":"2010-12-31","revenueHistory":[{"value":387126000,"period":"2010-12-31"},{"value":312333000,"period":"2009-12-31"},{"value":303976000,"period":"2008-12-31"}],"grossProfit":2711013000,"grossProfitHistory":[{"period":"2025-12-31","value":2711013000},{"period":"2024-12-31","value":2799159000},{"period":"2023-12-31","value":2706863000},{"period":"2022-12-31","value":2633775000}],"rdSpend":369911000,"rdSpendHistory":[{"period":"2025-12-31","value":369911000},{"period":"2024-12-31","value":364202000},{"period":"2023-12-31","value":346830000},{"period":"2022-12-31","value":305258000}],"sgaSpend":1755791000,"operatingIncome":585311000,"operatingIncomeHistory":[{"period":"2025-12-31","value":585311000},{"period":"2024-12-31","value":671764000},{"period":"2023-12-31","value":656654000},{"period":"2022-12-31","value":654048000}],"netIncome":410351000,"netIncomeHistory":[{"period":"2025-12-31","value":410351000},{"period":"2024-12-31","value":421362000},{"period":"2023-12-31","value":445053000},{"period":"2022-12-31","value":361573000}],"eps":5.65,"epsHistory":[{"period":"2025-12-31","value":5.65},{"period":"2024-12-31","value":5.62},{"period":"2023-12-31","value":5.81},{"period":"2022-12-31","value":4.61}],"cash":1094908000,"cashHistory":[{"period":"2025-12-31","value":1094908000},{"period":"2024-12-31","value":1043887000},{"period":"2023-12-31","value":937438000},{"period":"2022-12-31","value":942050000}],"totalAssets":6233693000,"totalLiabilities":2184546000,"totalDebt":114446000,"equity":4049147000,"operatingCashflow":593223000,"operatingCashflowHistory":[{"period":"2025-12-31","value":593223000},{"period":"2024-12-31","value":738231000},{"period":"2023-12-31","value":785776000},{"period":"2022-12-31","value":568732000}],"capex":-102445000,"capexHistory":[{"period":"2025-12-31","value":-102445000},{"period":"2024-12-31","value":-115580000},{"period":"2023-12-31","value":-177716000},{"period":"2022-12-31","value":-291900000}],"freeCashflow":490778000,"dividendsPaid":null,"buybacks":-465939000,"employees":20275,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":null,"ebitda":null,"period":"2026-03-31","revenue":null,"epsBasic":1.58,"netIncome":null,"rdExpense":null,"epsDiluted":1.57,"grossProfit":null,"operatingIncome":null},{"sga":441676000,"ebit":158875000,"ebitda":260870000,"period":"2025-12-31","revenue":1047561000,"epsBasic":1.89,"netIncome":135760000,"rdExpense":83036000,"epsDiluted":1.89,"grossProfit":683587000,"operatingIncome":158875000},{"sga":417800000,"ebit":128125000,"ebitda":183842000,"period":"2025-09-30","revenue":995692000,"epsBasic":0.78,"netIncome":56753000,"rdExpense":93276000,"epsDiluted":0.78,"grossProfit":639201000,"operatingIncome":128125000},{"sga":448686000,"ebit":163033000,"ebitda":203609000,"period":"2025-06-30","revenue":1012449000,"epsBasic":1.72,"netIncome":124608000,"rdExpense":96398000,"epsDiluted":1.72,"grossProfit":708117000,"operatingIncome":163033000},{"sga":447629000,"ebit":135278000,"ebitda":174426000,"period":"2025-03-31","revenue":979262000,"epsBasic":1.27,"netIncome":93230000,"rdExpense":97201000,"epsDiluted":1.27,"grossProfit":680108000,"operatingIncome":135278000},{"sga":424971000,"ebit":177092000,"ebitda":215221000,"period":"2024-12-31","revenue":995219000,"epsBasic":null,"netIncome":103807000,"rdExpense":94878000,"epsDiluted":null,"grossProfit":696941000,"operatingIncome":177092000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":161.72,"previousClose":161.75,"fiftyTwoWeekHigh":208.31,"fiftyTwoWeekLow":122,"fiftyTwoWeekRange":"122.0 - 208.31","fiftyDayAverage":176.15,"twoHundredDayAverage":157.32,"beta":1.7,"enterpriseValue":10640442368,"forwardPE":13.1,"priceToBook":2.79,"priceToSales":2.83,"enterpriseToRevenue":2.6,"enterpriseToEbitda":11.95,"pegRatio":0.89,"ebitda":890456000,"ebitdaMargin":21.7,"freeCashflow":538981504,"operatingCashflow":691588992,"totalDebt":116044000,"debtToEquity":2.8,"currentRatio":1.39,"returnOnAssets":7.3,"returnOnEquity":10.8,"analystRating":"1.9 - Buy","recommendationKey":"buy","numberOfAnalysts":14,"targetMeanPrice":209.07,"targetHighPrice":240,"targetLowPrice":175,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":6.8,"institutionHeldPercent":102.5,"sharesOutstanding":71618127,"floatShares":67041013,"sharesShort":4264231,"shortRatio":4.04,"shortPercentOfFloat":5.9,"epsTrailing":5.95,"epsForward":12.37,"revenuePerShare":56.88,"bookValue":57.94,"officers":[{"age":68,"name":"Mr. Joseph M. Hogan","title":"President, CEO & Director"},{"age":58,"name":"Mr. John F. Morici","title":"CFO & Executive VP of Global Finance"},{"age":57,"name":"Ms. Julie Ann Coletti J.D.","title":"Executive VP and Chief Legal & Regulatory Officer"},{"age":60,"name":"Mr. Zelko  Relic","title":"Executive VP & CTO"},{"age":null,"name":"Ms. Shirley  Stacy","title":"Vice President of Corporate Communications & Investor Relations"},{"age":null,"name":"Richardson Jaime Holte","title":"Executive Vice President of Global Human Resources"},{"age":55,"name":"Mr. Emory M. Wright","title":"Executive Vice President of Direct Fabrication Platform & Operations"},{"age":50,"name":"Ms. Sreelakshmi  Kolli","title":"Executive VP and Chief Product & Digital Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://investor.aligntech.com/","website":"https://www.aligntech.com","phone":"602 742 2000"}}